Despite facing a third wave of COVID-19 with more transmissible variants, Germany is projected to return to pre-pandemic levels by 2022, ahead of its Western European peers.

FrontierView’s most recent Germany Market Review explores several key market developments: 

  • Economic delays from the third lockdown will not be as detrimental
  • German citizens will be offered more opportunities than their European peers
  • The key to recovery will be a manufacturing boom in the second half of 2021 

Managing COVID-19 

The European Commission’s misjudgments of the procurement of vaccines, combined with delayed vaccine orders, caused shortages in the first quarter of 2021. A solid supply of vaccines is expected in the second quarter of 2021 which will allow adults over 60 to be vaccinated by June/July, and the general population by the end of October. Strict restrictions in Germany will likely be necessary until August (at the latest). 

The path to recovery 

Continued government stimulus is vital to a successful economic restart in 2021. While manufacturing is key to recovery, performance will vary by segment,  with food and pharma providing solid opportunities. Germany remains the most attractive country for doing business within Western Europe, as it is comparatively more insulated from fiscal, political, and financial risks.

Read our latest Germany Market Review to provide your business with the resources to succeed in Western Europe. 

At FrontierView, our mission is to help our clients grow and win in their most important markets. We provide the research, data, and insights you need to outperform the competition. Our customizable market intelligence turns information into real-time insights that you can act on with confidence. For full access to our offerings, start your free trial today and download our complimentary mobile app, available on iOS and Android